Business
Pacific Biosciences Announces Retirement of Michael Phillips, SVP of Research and Development
Dr. Denis Zaccarin Succeeds Phillips to Lead Research and Development MENLO PARK, Calif., Feb. 07, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California,
About this update from Pacific Biosciences Of California, Inc.
[{"type":"text","content":"Dr. Denis Zaccarin Succeeds Phillips to Lead Research and Development\nMENLO PARK, Calif., Feb. 07, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, today announced that Michael Phillips has decided to retire from his role as the company’s Senior Vice President of Research and Development as of April 1, 2020.\n Mr. Phillips has directed the development of PacBio’s technology since joining the company in 2005. During his tenure, he oversaw the development of the company’s first system, the PacBio RS, which was launched in 2011, and each of the company’s follow-on systems, including the PacBio RS II in 2013, the Sequel System in 2015, and most recently the Sequel II System in 2019. “It has truly been an honor to lead Research and Development at Pacific Biosciences for the last 15 years. I have had the privilege of working with an exceptional team of scientists and engineers who have taken our technologies from the lab and transformed them into highly successful commercial products that are playing a principal role in the emerging genomics revolution. Even though I am concluding my career at PacBio, I look forward to following its progress and continued success, as Denis and the Research and Development team continue to push forward the technology’s potential,” said Mr. Phillips. “Michael has been a key contributor for PacBio since its early days, and he has been at the helm of the company’s R&D efforts throughout most of its history,” said Michael Hunkapiller, Chairman and Chief Executive Officer of Pacific Biosciences. “PacBio launched the first long-read sequencer in 2011 with its novel SMRT technology and has leveraged the same technology to produce sequencers today with up to 100,000 times the throughput of those early systems. We are fortunate to have had Michael lead our development efforts throughout this period. On behalf of myself and the company, I extend our thanks to Michael for his many contributions to PacBio.” Denis Zaccarin, PhD will succeed Mr. Phillips as the company’s head of research and development. Dr. Zaccarin joined PacBio in 2004 and has been an integral part of the company’s R&D team, most recently serving as Vice President of Semiconductor Integrated Devices, the team that is responsibl...